BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24367842)

  • 1. Advanced pelvic organ prolapse and routine health screening.
    Suozzi BA; Galffy A; O'Sullivan DM; Tulikangas PK
    Conn Med; 2013; 77(10):595-8. PubMed ID: 24367842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Pelvic Organ Prolapse and Non-Human Papillomavirus Pap Smear Abnormalities.
    Menhaji K; Harvie HS; Cheston E; Levin PJ; Arya LA; Andy UU
    Female Pelvic Med Reconstr Surg; 2018; 24(4):315-318. PubMed ID: 28708758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
    Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
    Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations in breast and colon cancer screening behavior in women.
    Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
    Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, risk factors, and predictors of pelvic organ prolapse: a community-based study.
    Awwad J; Sayegh R; Yeretzian J; Deeb ME
    Menopause; 2012 Nov; 19(11):1235-41. PubMed ID: 23096244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?
    Barber MD; Neubauer NL; Klein-Olarte V
    Am J Obstet Gynecol; 2006 Oct; 195(4):942-8. PubMed ID: 16681989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age, body mass index, and parity on Pelvic Organ Prolapse Quantification system measurements in women with symptomatic pelvic organ prolapse.
    Shalom DF; Lin SN; St Louis S; Winkler HA
    J Obstet Gynaecol Res; 2012 Feb; 38(2):415-9. PubMed ID: 22229672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
    Fang SY; Shu BC
    Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast and cervical cancer screening in Spain and predictors of adherence.
    Martín-López R; Hernández-Barrera V; De Andres AL; Garrido PC; De Miguel AG; García RJ
    Eur J Cancer Prev; 2010 May; 19(3):239-45. PubMed ID: 20110817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life.
    Jelovsek JE; Barber MD
    Am J Obstet Gynecol; 2006 May; 194(5):1455-61. PubMed ID: 16647928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional bowel and anorectal disorders in patients with pelvic organ prolapse and incontinence.
    Jelovsek JE; Barber MD; Paraiso MF; Walters MD
    Am J Obstet Gynecol; 2005 Dec; 193(6):2105-11. PubMed ID: 16325624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison outcomes of three surgical procedures in treatment of severe pelvic organ prolapse and analysis of risk factors for genital prolapse recurrence].
    Hu CD; Chen YS; Yi XF; Ding JX; Feng WW; Yao LQ; Huang J; Zhang Y; Hu WG; Zhu ZL; Hua KQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):94-100. PubMed ID: 21426765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of observation as therapy for pelvic organ prolapse: a study in the natural history of pelvic organ prolapse.
    Gilchrist AS; Campbell W; Steele H; Brazell H; Foote J; Swift S
    Neurourol Urodyn; 2013 Apr; 32(4):383-6. PubMed ID: 22907839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased incidence of pelvic organ prolapse in women with acromegaly.
    Celik O; Akhan SE; Hatipoglu E; Kadioglu P
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():44-7. PubMed ID: 25461351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky.
    Fleming ST; Love MM; Bennett K
    J Am Board Fam Med; 2011; 24(6):682-92. PubMed ID: 22086811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a culturally specific assessment tool for pelvic organ prolapse in a Mayan population.
    Overcash RT; Macri CJ
    Rural Remote Health; 2011; 11(1):1644. PubMed ID: 21344956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing acculturation scales and their relationship to cancer screening among older Mexican-American women.
    Suarez L; Pulley L
    J Natl Cancer Inst Monogr; 1995; (18):41-7. PubMed ID: 8562221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower abdominal and pelvic pain with advanced pelvic organ prolapse: a case-control study.
    Reddy J; Barber MD; Walters MD; Paraiso MF; Jelovsek JE
    Am J Obstet Gynecol; 2011 Jun; 204(6):537.e1-5. PubMed ID: 21345412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.